A number of other brokerages have also recently commented on GXI. Hauck & Aufhaeuser set a €60.00 ($69.77) price target on Gerresheimer and gave the stock a sell rating in a research note on Monday, October 8th. Goldman Sachs Group set a €70.00 ($81.40) price target on Gerresheimer and gave the stock a neutral rating in a research note on Monday, June 18th. DZ Bank reaffirmed a buy rating on shares of Gerresheimer in a research note on Thursday, July 12th. HSBC set a €67.00 ($77.91) price target on Gerresheimer and gave the stock a neutral rating in a research note on Monday, July 16th. Finally, Kepler Capital Markets set a €65.00 ($75.58) price objective on Gerresheimer and gave the stock a sell rating in a research report on Thursday, July 12th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. Gerresheimer currently has a consensus rating of Hold and an average target price of €71.67 ($83.33).
Gerresheimer stock traded down €2.85 ($3.31) during trading hours on Friday, reaching €61.50 ($71.51). The company had a trading volume of 389,276 shares, compared to its average volume of 140,925. Gerresheimer has a 12-month low of €59.97 ($69.73) and a 12-month high of €78.25 ($90.99).
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Featured Story: Understanding Average Daily Trade Volume
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.